These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 21726494

  • 1. Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine, and venlafaxine in Korean patients with major depressive disorder.
    Jung YE, Jun TY, Kim KS, Bahk WM.
    Int J Clin Pharmacol Ther; 2011 Jul; 49(7):437-43. PubMed ID: 21726494
    [Abstract] [Full Text] [Related]

  • 2. Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Al-Adwani A.
    Can J Psychiatry; 2005 Nov; 50(13):877; author reply 877-8. PubMed ID: 16483124
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
    Khandker RK, Kruzikas DT, McLaughlin TP.
    J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
    [Abstract] [Full Text] [Related]

  • 4. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
    Thase ME, Nierenberg AA, Vrijland P, van Oers HJ, Schutte AJ, Simmons JH.
    Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
    [Abstract] [Full Text] [Related]

  • 5. Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Benazzi F.
    Can J Psychiatry; 2005 Mar; 50(3):184. PubMed ID: 15830829
    [No Abstract] [Full Text] [Related]

  • 6. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
    Sung SC, Haley CL, Wisniewski SR, Fava M, Nierenberg AA, Warden D, Morris DW, Kurian BT, Trivedi MH, Rush AJ, CO-MED Study Team.
    J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
    [Abstract] [Full Text] [Related]

  • 7. Antidepressants and the risk of hyponatremia: a class-by-class review of literature.
    De Picker L, Van Den Eede F, Dumont G, Moorkens G, Sabbe BG.
    Psychosomatics; 2014 Jul; 55(6):536-47. PubMed ID: 25262043
    [Abstract] [Full Text] [Related]

  • 8. Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis.
    Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M, Salanti G.
    Lancet Psychiatry; 2019 Jul; 6(7):601-609. PubMed ID: 31178367
    [Abstract] [Full Text] [Related]

  • 9. Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
    Bateman DN, Chick J, Good AM, Kelly CA, Masterton G.
    Eur J Clin Pharmacol; 2004 May; 60(3):221-4. PubMed ID: 15083251
    [Abstract] [Full Text] [Related]

  • 10. Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults.
    Jacob S, Spinler SA.
    Ann Pharmacother; 2006 Sep; 40(9):1618-22. PubMed ID: 16896026
    [Abstract] [Full Text] [Related]

  • 11. Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit.
    Kirby D, Harrigan S, Ames D.
    Int J Geriatr Psychiatry; 2002 Mar; 17(3):231-7. PubMed ID: 11921151
    [Abstract] [Full Text] [Related]

  • 12. Syndrome of inappropriate secretion of antidiuretic hormone due to citalopram and venlafaxine.
    Romero S, Pintor L, Serra M, Plana T, Navarro V, Gastó C, Goldstein B.
    Gen Hosp Psychiatry; 2007 Mar; 29(1):81-4. PubMed ID: 17189754
    [Abstract] [Full Text] [Related]

  • 13. [Antidepressant treatment associated hyponatremia -- case report].
    Bognár Z, Vonyik G, Gazdag G.
    Neuropsychopharmacol Hung; 2013 Sep; 15(3):177-80. PubMed ID: 24108183
    [Abstract] [Full Text] [Related]

  • 14. Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis.
    Gartlehner G, Hansen RA, Carey TS, Lohr KN, Gaynes BN, Randolph LC.
    Int Clin Psychopharmacol; 2005 Mar; 20(2):59-69. PubMed ID: 15729080
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH, Andersen HF, Lam RW.
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [Abstract] [Full Text] [Related]

  • 16. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE, McKenzie JE, Bailey AP, Sharma V, Moller CI, Badcock PB, Cox GR, Merry SN, Meader N.
    Cochrane Database Syst Rev; 2021 May 24; 5(5):CD013674. PubMed ID: 34029378
    [Abstract] [Full Text] [Related]

  • 17. Reboxetine adjunct for partial or nonresponders to antidepressant treatment.
    Rubio G, San L, López-Muñoz F, Alamo C.
    J Affect Disord; 2004 Jul 24; 81(1):67-72. PubMed ID: 15183602
    [Abstract] [Full Text] [Related]

  • 18. Saliva levels of 3-methoxy-4-hydroxyphenylglycol and clinical efficacy of mirtazapine or selective serotonin reuptake inhibitors in patients with major depression.
    Egami M, Imamura Y, Nabeta H, Mizoguchi Y, Yamada S.
    Hum Psychopharmacol; 2013 Jan 24; 28(1):7-14. PubMed ID: 23124792
    [Abstract] [Full Text] [Related]

  • 19. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L, Corcos M, Jeammet P.
    Encephale; 2005 Jan 24; 31(3):309-16. PubMed ID: 16142045
    [Abstract] [Full Text] [Related]

  • 20. Antidepressants and the risk of hyponatremia: a Danish register-based population study.
    Leth-Møller KB, Hansen AH, Torstensson M, Andersen SE, Ødum L, Gislasson G, Torp-Pedersen C, Holm EA.
    BMJ Open; 2016 May 18; 6(5):e011200. PubMed ID: 27194321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.